Coya Therapeutics (COYA) Common Equity (2022 - 2025)
Historic Common Equity for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $27.3 million.
- Coya Therapeutics' Common Equity fell 1476.31% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 million, marking a year-over-year decrease of 1476.31%. This contributed to the annual value of $39.6 million for FY2024, which is 1106.05% up from last year.
- According to the latest figures from Q3 2025, Coya Therapeutics' Common Equity is $27.3 million, which was down 1476.31% from $28.3 million recorded in Q2 2025.
- In the past 5 years, Coya Therapeutics' Common Equity ranged from a high of $39.6 million in Q4 2024 and a low of -$8.4 million during Q4 2022
- In the last 4 years, Coya Therapeutics' Common Equity had a median value of $30.2 million in 2024 and averaged $24.6 million.
- As far as peak fluctuations go, Coya Therapeutics' Common Equity skyrocketed by 52455.97% in 2023, and later tumbled by 1970.21% in 2025.
- Quarter analysis of 4 years shows Coya Therapeutics' Common Equity stood at -$8.4 million in 2022, then surged by 524.56% to $35.6 million in 2023, then grew by 11.06% to $39.6 million in 2024, then plummeted by 31.06% to $27.3 million in 2025.
- Its last three reported values are $27.3 million in Q3 2025, $28.3 million for Q2 2025, and $33.4 million during Q1 2025.